ABSTRACT
Therapeutic angiogenesis has been evolving for over two decades and accordingly, pre-clinical studies have increased evidence that a variety of growth factors and stem/progenitor cells may be employed therapeutically for repair of ischemic tissue. This forward-thinking session will discuss cytokine and cell therapies as viable treatments for patients with ischemic diseases.
LEARNING OBJECTIVES
• Review the role of the microcirculation in ischemic disease pathophysiology
• Define endothelial progenitors' role in ischemic tissue repair
• Identify early phase clinical studies using cell based approaches to treat peripheral artery disease
